Biogen Inc (NASDAQ:BIIB) | Financial Trends

Health

Abbvie Inc (NYSE:ABBV), Samsung Bioepis In Deal; Humira Biosimilar U.S. Release...

Ash Sandifer -

BIOTECH

Biogen Inc. (NASDAQ:BIIB) presents Phase 1b data for aducanumab

Aaron Lyons -

Business

Biogen Inc (NASDAQ:BIIB) Sheds More Than $20 Billion In Market Value...

Brandon Manns -